Inhibition of melanoma cell motility by the snake venom disintegrin eristostatin (cas 132051-67-3)

Add time:07/28/2019    Source:sciencedirect.com

Eristostatin, an RGD-containing disintegrin isolated from the venom of Eristicophis macmahoni, inhibits lung or liver colonization of melanoma cells in a mouse model. In this study, transwell migration and in vitro wound closure assays were used to determine the effect of eristostatin on the migration of melanoma cells. Eristostatin significantly impaired the migration of five human melanoma cell lines. Furthermore, it specifically inhibited cell migration on fibronectin in a concentration-dependent manner, but not that on collagen IV or laminin. In contrast, eristostatin was found to have no effect on cell proliferation or angiogenesis. These results indicate that the interaction between eristostatin and melanoma cells may involve fibronectin-binding integrins that mediate cell migration. Mutations to alanine of seven residues within the RGD loop of eristostatin and four residues outside the RGD loop of eristostatin resulted in significantly less potency in both platelet aggregation and wound closure assays. For six of the mutations, however, decreased activity was found only in the latter assay. We conclude that a different mechanism and/or integrin is involved in these two cell activities.

We also recommend Trading Suppliers and Manufacturers of eristostatin (cas 132051-67-3). Pls Click Website Link as below: cas 132051-67-3 suppliers

Prev:Effect of the disintegrin eristostatin (cas 132051-67-3) on melanoma–natural killer cell interactions
Next:Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin (cas 132051-67-3) for recognition of αIIbβ3 and αvβ3 integrins)